We are live on
!
Find out more
Aberdeen Group Portfolio holdings
AUM
$71.2B
Turnover
9.3%
1-Year Est. Return
41.74%
This Fund
S&P 500
This Quarter
Est. Return
-15.01%
1 Year Est. Return
+41.74%
3 Year Est. Return
+120.47%
5 Year Est. Return
+149.18%
10 Year Est. Return
–
AUM
$31.8B
AUM Growth
-$7.3B
(-19%)
Cap. Flow
-$363M
Cap. Flow
% of AUM
-1.14%
Top 10 Holdings %
Top 10 Hldgs %
23.56%
Holding
999
New
22
Increased
368
Reduced
528
Closed
49
Avg Time Held
3.4
years
Top 10 Avg Time Held
2.3
years
Top 20 Avg Time Held
1.8
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$175M |
| 2 |
Banco Santander Chile
BSAC
|
+$99.6M |
| 3 |
Royalty Pharma
RPRX
|
+$54.4M |
| 4 |
Charles Schwab
SCHW
|
+$50.5M |
| 5 |
Darling Ingredients
DAR
|
+$43.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$181M |
| 2 |
NextEra Energy
NEE
|
+$167M |
| 3 |
Huntington Bancshares
HBAN
|
+$166M |
| 4 |
AbbVie
ABBV
|
+$88.9M |
| 5 |
PayPal
PYPL
|
+$73.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.22% |
| 2 | Healthcare | 13.71% |
| 3 | Financials | 13.45% |
| 4 | Consumer Discretionary | 10.94% |
| 5 | Industrials | 9.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1
Microsoft
MSFT
$3.96T
| $1.84B | 5.78% |
7,109,305
-52,592
| -0.7% | -$14.3M |
2017 Q3
19 quarters
|
|
2
Apple
AAPL
$5.01T
| $1.36B | 4.27% |
9,882,458
-129,355
| -1% | -$19.6M |
2017 Q3
19 quarters
|
|
3
Amazon
AMZN
$2.74T
| $914M | 2.87% |
8,568,473
+311,733
| +4% | +$39M |
2017 Q3
19 quarters
|
|
4
Alphabet (Google) Class A
GOOGL
$4.25T
| $741M | 2.33% |
6,733,700
-143,640
| -2% | -$16.9M |
2017 Q3
19 quarters
|
|
5
Mastercard
MA
$528B
| $525M | 1.65% |
1,656,663
-60,040
| -3% | -$20.7M |
2017 Q3
19 quarters
|
|
6
UnitedHealth
UNH
$355B
| $502M | 1.58% |
977,731
+30,218
| +3% | +$15.2M |
2017 Q3
19 quarters
|
|
7
Alphabet (Google) Class C
GOOG
$4.2T
| $464M | 1.46% |
4,199,860
-36,160
| -0.9% | -$4.27M |
2017 Q3
19 quarters
|
|
|
8
AbbVie
ABBV
$501B
| $463M | 1.46% |
3,027,875
-581,525
| -16% | -$88.9M |
2017 Q3
19 quarters
|
|
9
Coca-Cola
KO
$395B
| $377M | 1.18% |
6,000,257
+566,940
| +10% | +$35.9M |
2017 Q3
19 quarters
|
|
10
Boston Scientific
BSX
$62.3B
| $315M | 0.99% |
8,383,219
-308,985
| -4% | -$12.6M |
2017 Q3
19 quarters
|
|
11
American Tower
AMT
$83.6B
| $313M | 0.98% |
1,225,623
-30,251
| -2% | -$7.59M |
2017 Q3
19 quarters
|
|
12
Broadcom
AVGO
$1.65T
| $309M | 0.97% |
6,301,480
-141,290
| -2% | -$7.93M |
2018 Q3
15 quarters
|
|
13
Banco Bradesco
BBD
$46.3B
| $297M | 0.93% |
90,280,790
+35,838
| +0% | +$138K |
2017 Q3
19 quarters
|
|
14
TJX Companies
TJX
$157B
| $296M | 0.93% |
5,246,503
+421,546
| +9% | +$25.5M |
2017 Q3
19 quarters
|
|
15
Procter & Gamble
PG
$364B
| $291M | 0.92% |
2,038,402
+87,333
| +4% | +$13.1M |
2017 Q3
19 quarters
|
|
16
Fomento Económico Mexicano
FMX
$41.1B
| $290M | 0.91% |
4,328,075
-56,781
| -1% | -$4.2M |
2017 Q3
19 quarters
|
|
17
Emerson Electric
EMR
$89.9B
| $278M | 0.87% |
3,480,440
+164,505
| +5% | +$14.5M |
2017 Q3
19 quarters
|
|
18
Analog Devices
ADI
$196B
| $274M | 0.86% |
1,851,062
-76,925
| -4% | -$12.1M |
2017 Q3
19 quarters
|
|
|
19
Merck
MRK
$364B
| $265M | 0.83% |
2,886,936
+1,969,911
| +215% | +$175M |
2017 Q3
19 quarters
|
|
|
20
Charles Schwab
SCHW
$167B
| $258M | 0.81% |
4,103,106
+732,479
| +22% | +$50.5M |
2017 Q3
19 quarters
|
|
21
Goldman Sachs
GS
$256B
| $249M | 0.78% |
839,185
-23,037
| -3% | -$7.17M |
2017 Q3
19 quarters
|
|
22
Philip Morris
PM
$320B
| $247M | 0.78% |
2,514,817
-103,220
| -4% | -$10.5M |
2017 Q3
19 quarters
|
|
23
Eli Lilly
LLY
$1.08T
| $247M | 0.78% |
764,274
+11,344
| +2% | +$3.41M |
2017 Q3
19 quarters
|
|
24
Lowe's Companies
LOW
$106B
| $243M | 0.76% |
1,390,978
-32,351
| -2% | -$6.24M |
2017 Q3
19 quarters
|
|
25
Baker Hughes
BKR
$55B
| $240M | 0.75% |
8,152,456
-172,105
| -2% | -$5.82M |
2017 Q3
19 quarters
|
|
Similar funds
Aberdeen Group's Q2 2022 Portfolio in Review
As of Q2 2022, Aberdeen Group held 999 positions worth $31.8B, down 19% from $39.1B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Aberdeen Group's Q2 2022 filing shows 22 new, 368 increased, 528 reduced and 49 closed positions. Its largest new stake was American Equity Investment Life Holding Company: 517,688 shares worth $18.8M. The largest sale was Meta Platforms (Facebook), an estimated $181M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 24% a quarter earlier, followed by Healthcare and Financials.
- Aberdeen Group's largest Q2 2022 buy was American Equity Investment Life Holding Company: 517,688 shares worth $18.8M.
- Aberdeen Group added most to Merck in Q2 2022, an estimated $175M increase.
- Aberdeen Group's biggest Q2 2022 reduction was Meta Platforms (Facebook), cutting an estimated $181M.
- Aberdeen Group fully exited iShares iBoxx $ High Yield Corporate Bond ETF in Q2 2022, selling an estimated $46.5M.
- Aberdeen Group's ten largest holdings make up 24% of its $31.8B portfolio in Q2 2022.
- Aberdeen Group opened 22 new positions and closed 49 in Q2 2022.
- Aberdeen Group's portfolio value fell 19% quarter-over-quarter to $31.8B.
Based on Aberdeen Group's 13F filing for Q2 2022, filed 5 Aug 2022.